News & Perspective

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Part 1: Flu research: a legacy of neglect

Editor's note: This is the first in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Aug 25, 2008

Aug 25, 2008

H1N1 flu viruses growing more resistant to Tamiflu

(CIDRAP News) – With influenza season well under way in the southern hemisphere, one of the three kinds of seasonal influenza virus is becoming increasingly resistant to the antiviral drug oseltamivir (Tamiflu), the World Health Organization (WHO) reported last week.

Nov 20, 2009

Nov 20, 2009

Clusters of resistant H1N1 cases reported in UK, US

(CIDRAP News) – Health officials in Wales today announced the identification of a cluster of patients in a Cardiff hospital who are infected with oseltamivir-resistant pandemic H1N1 influenza.

Dec 03, 2009

Dec 03, 2009

WHO: It's too early to say pandemic has peaked

(CIDRAP News) – The World Health Organization's (WHO's) top influenza expert said today it's too soon to judge whether the H1N1 influenza pandemic has passed its peak, though he acknowledged that cases are dropping in the United States and Canada.

Dec 28, 2009

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»